Format

Send to

Choose Destination
Genet Med. 2018 Dec 22. doi: 10.1038/s41436-018-0391-z. [Epub ahead of print]

Patient re-contact after revision of genomic test results: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG).

Author information

1
Division of Genetics, Department of Medicine, NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY, USA. kld9001@nyp.org.
2
University of South Carolina School of Medicine Greenville and Greenville Health System, Greenville, SC, USA.
3
Regional Precision Tracking and Genetics Department, Kaiser Permanente Northern California, Oakland, CA, USA.
4
Pediatric Clinical Genetics, Columbia University Medical Center, New York, USA.
5
Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA.
6
Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
7
Center for Personalized Genetic Healthcare, Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
8
Division of Genetics, Department of Pediatrics, Boston Medical Center, Boston, MA, USA.
9
Division of Genetics and Genomics and the Manton Center for Orphan Disease Research, Boston Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
10
Genetic Alliance, Washington, DC, USA.
11
Division of Translational Medicine and Human Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.

KEYWORDS:

clinical genetics; duty to re-contact; medical ethics; reinterpretation of genomic results; variant reclassification

PMID:
30578420
DOI:
10.1038/s41436-018-0391-z

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center